Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,622 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07443410Recruiting
Probiotics for gum disease treatment
This trial tests whether taking pre- and probiotics alongside non-surgical gum treatment improves healing and reduces harmful bacteria. It may help people with advanced gum disease (stage III or IV periodontitis).
Heidelberg, Baden-WurttembergAges 18 years+ - NCT07444047Recruiting
MRI study of brain lesions in older MS patients
This study uses MRI scans to compare brain lesions in older patients with multiple sclerosis versus those with small vessel disease. It aims to improve how doctors tell apart these conditions and may lead to better treatment choices.
Oslo, OsloAges 50–80 - NCT07444060Recruiting
Guselkumab vs Ustekinumab for stricturing Crohn's disease
This study compares two medicines, Guselkumab and Ustekinumab, for people with Crohn's disease that causes narrowing (strictures) in the bowel. It aims to find which works better to improve symptoms and avoid the need for more procedures.
Hangzhou, ZhejiangAges 18–80 - NCT07444216Recruiting
A study on hope in teens and young adults with advanced cancer
This study explores hope in patients aged 12-25 with pediatric cancer that has returned, not responded to treatment, or has no cure. Participants take photos and share their stories to help doctors and families understand what hope means during early-phase clinical trials (phase 1 or 2).
Memphis, TennesseeAges 12 years+ - NCT07444372Recruiting
CPAP for Sleep Apnea After Atrial Fibrillation Ablation
This trial tests whether starting CPAP therapy (a breathing mask used during sleep) after a heart procedure called atrial fibrillation ablation can help people with both sleep apnea and atrial fibrillation. It might lower the chance of the heart rhythm problem coming back.
Beijing, Beijing MunicipalityAges 18–75 - NCT07444788RecruitingPhase 1
Acute effects of 5-MeO-DMT in healthy people
This study tests a single dose of a fast-acting psychedelic called 5-MeO-DMT given through a vein. It is only for healthy volunteers who have no medical or mental health conditions and limited previous experience with hallucinogens.
Basel, Canton of Basel-CityAges 25–65 - NCT07444801Recruiting
Tralokinumab for eczema with genital symptoms
This trial tests if tralokinumab, a drug already approved for moderate-to-severe eczema, helps people who also have eczema in the genital area. It aims to understand how well the drug works for this specific symptom.
Augsburg, MünchenAges 18 years+ - NCT07444879Recruiting
Blood markers in panic disorder
This study looks at certain blood markers (IL-33, sST2, and CRP) in people with panic disorder to see if they are different from healthy individuals. It may help researchers understand more about panic disorder.
Elâzığ, ElâzığAges 18–65 - NCT07444853Recruiting
Improving recovery after brain hemorrhage
This study looks at people who come to the emergency room with a bleeding stroke (called intracerebral hemorrhage). It aims to learn more about the condition by studying blood tests and brain scans, to find ways to improve outcomes.
AngersAges 18 years+ - NCT07444931Recruiting
Predicting cardiac arrest risk in heart disease patients
This study looks at factors that may help predict sudden cardiac arrest in people with coronary artery disease. If you have a recent diagnosis of significant blockage or a heart attack, joining this trial could help improve risk assessment.
HaderaAges 18–75 - NCT07445048RecruitingPhase 3
Radiation, targeted therapy, and immunotherapy for high-risk head and neck cancer
This trial tests if adding a targeted drug (nimotuzumab) and an immunotherapy (benmelstobart) after surgery and radiation can help prevent cancer from returning in patients with high-risk head and neck cancer who cannot take cisplatin chemotherapy.
ShanghaiAges 18 years+ - NCT07445386Recruiting
Nerve block for upper abdominal cancer pain
This trial compares two types of nerve blocks to treat severe pain from upper abdominal cancers like stomach, pancreas, or liver cancer. It may be an option if your pain hasn't been controlled with standard treatments.
AnkaraAges 18 years+ - NCT07446608Recruiting
MRI to predict response to dienogest for endometriosis
This study uses MRI scans to see if they can predict how well dienogest, a hormone treatment, will work for endometriosis. If you have endometriosis and haven't used dienogest before, this trial could help find the best treatment for you.
Sejong, Sejong Special Self-Governing CityAges 19–45 - NCT07446842Recruiting
AI model for better diagnosis of brain diseases
This study is building an artificial intelligence system to improve how doctors diagnose brain conditions using scans like MRI. If you are diagnosed with one of the listed conditions, your scans and medical information may help train the AI.
Wuhan, HubeiAges Any age - NCT07447453Recruiting
Motivational support for exercise in healthy aging
This trial tests if motivational support can help adults 70+ stay active with a home exercise program. It may help you maintain strength and mobility as you age.
Getafe, MadridAges 70 years+ - NCT07447570RecruitingPhase 2
Iparomlimab and Tuvonralimab plus radiation and chemo for head and neck cancer
This trial tests a combination of two immunotherapy drugs (Iparomlimab and Tuvonralimab) with low-dose radiation and chemotherapy for advanced head and neck cancer. It aims to see if this approach can help patients who have not had prior treatment for their cancer.
Hangzhou, ZhejiangAges 18–75 - NCT07448090Recruiting
Obesity treatment real-world study
This study looks at how obesity treatments work in real life for adults with a high body mass index. It aims to help doctors understand what works best for different people.
Wuhan, HubeiAges 18–75 - NCT07448324RecruitingPhase 2
Orelabrutinib plus rituximab with or without lenalidomide for untreated MZL
This trial tests a combination of targeted drugs for people with a type of lymphoma called marginal zone lymphoma (MZL) that has not been treated before. The drugs attack cancer cells in different ways, and the treatment plan may adjust based on how you respond.
Nanjing, JiangsuAges 18 years+ - NCT07448298RecruitingEarly Phase 1
Testing AFN50 for hard-to-treat autoimmune diseases
This study tests an experimental drug called AFN50 for people with certain autoimmune diseases that have not responded to standard treatments. It aims to see if AFN50 can help control the disease.
BeijingAges 18–69 - NCT07448896Recruiting
Studying immune cells in stomach tissue after weight loss surgery
This study looks at how certain immune cells (mast cells and macrophages) and small blood vessels change in the stomach tissue of people who have weight loss surgery. It may help researchers better understand how the body responds to surgery and weight loss.
Alexandria, Alexandria GovernorateAges Any age - NCT07449793Recruiting
PBC treatment response and long-term health outcomes
This research study tracks how well Primary Biliary Cholangitis (PBC) responds to standard medication (UDCA) and what happens to patients' health over time. It may help doctors understand which treatments work best for different people.
Shanghai, Shanghai MunicipalityAges 18–85 - NCT07449897Recruiting
Gallstone removal during gallbladder surgery study
This study tests a method to remove bile duct stones during gallbladder surgery, aiming to treat both problems in one procedure.
OsloAges 18 years+ - NCT07450014Recruiting
Does anxiety before surgery affect risks from spinal anesthesia?
This study looks at whether how anxious you feel before surgery affects your risk of a sudden drop in heart rate and blood pressure (vasovagal event) when you receive spinal anesthesia. Participation may help doctors better understand and prevent these episodes.
SanliurfaAges 18–65 - NCT07450027Recruiting
Blood markers in methamphetamine psychosis
This study looks at two blood proteins (LRFN5 and OLFM4) in people with methamphetamine use disorder or methamphetamine-induced psychosis, compared to healthy controls. Results may help understand the biology of these conditions.
Elâzığ, ElâzığAges 18–49
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,622 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.